Varaporn Buraphacheep Junyaprasert et al.
International journal of pharmaceutics, 352(1-2), 81-91 (2007-12-07)
A sustained release suspension of diltiazem, a short half-life calcium channel blocker, was developed to reduce frequency of drug administration, ease of dose adjustment and improve patient compliance. In this study, the sustained release of diltiazem was obtained by complexing